11094435908632364994308624

  Rare Revolution Magazine
  • Home
  • Rare Revolutionaries
    • Our Charity Partners
    • Revolutionaries Community
    • Join the Rare Revolution - Charities sign-up
    • Our Corporate Friends
  • Blog
  • Back Issues
  • #RareYouthProject
    • RYP Blog
  • The People of RARE
    • CEO Series
  • APP & Downloads
  • Media

RARE INSIGHTS

Alan Finglas, founder of MSD Action Foundation and Saving Dylan, contemplates EU policy and the potential it has to open the gates for real change in the rare disease community

28/7/2020

0 Comments

 
Picture
Picture
​After attending the 10th European Conference on Rare Diseases & Orphan Products (ECRD) in May, Alan Finglas founder and research manager of MSD Action Foundation and SavingDylan.com explains his hopes and fears in the coming years of how EU policy will shape the rare disease landscape and the importance it will play in driving change. Alan is concerned how things will look in the next five to 10 years unless huge improvements are made and how he has been inspired to write about two priority items that he feels must be delivered in order to drive real change for the rare disease community.
I sometimes think of the landscape in the rare disease space when my son was diagnosed five years ago, where we are today and where we might be in the next five to 10 years’ time. This gives me a complete mixture of emotions. Positive things have been achieved but we must do much, much, more.

... I think we are all agreed that changing EU policy on rare diseases is very essential work.
Attending ECRD 2020

The European Rare Disease Conference (ERDC) was held online on 14th and 15th May 2020. It was the largest online conference that I have participated in. It was a positive experience overall and I am encouraged that in the next six months Eurordis plan to pull together their medium to long term EU policy strategies for rare diseases. I think we are all agreed that changing EU policy on rare diseases is very essential work. I would like to take this opportunity to thank Eurordis, the European Reference Networks (ERN’s) that cover rare diseases and every patient advocate that works towards change for patients and their families that are affected. 
Picture
Alan with his family
Alan and his family

My son Dylan (7) suffers from an ultra-rare disorder called multiple sulfatase deficiency (MSD). As a result of my research efforts for MSD, and advocacy for rare diseases in general, I feel that I have gained a deep insight into the rare disease world over the past five years. Dylan’s condition is life limiting and progressive therefore I always want as much positive change sooner rather than later. I understand long-term strategies are necessary, however, I believe the patient (or caregivers) voice is extremely powerful to bring about more timely positive change.
​
I sometimes think of the landscape in the rare disease space when my son was diagnosed five years ago, where we are today and where we might be in the next five to 10 years’ time. This gives me a complete mixture of emotions. Positive things have been achieved but we must do much, much, more.
Multiple sulfatase deficiency: 
Is a complex, inherited disorder caused by a genetic mutation. The condition results in the dysfunction of specialised proteins known as enzymes responsible for the breakdown of certain sugars and fats in the body. As a result, these sugar and fat molecules accumulate to toxic levels in many of the body’s tissues and organ systems, especially the central nervous and skeletal systems. Because the disease affects different children at many different stages, multiple sulfatase deficiency is often classified as “neonatal,” “late-infantile,” or “juvenile.” Multiple sulfatase deficiency is one of about 50 diseases classified as lysosomal storage disorders (LSD).

Source: Boston Children's Hospital
​
EU policies are required to open the gates for real change in rare disease

I do fear how things will look in five to 10 years if we fail to make these huge improvements that ultimately help patients and their families. I would hate to be in a situation, looking back, saying “we could and should have done so much better.”

This inspired me to write about two priority items that I feel we must deliver on. There are many other particularly important EU policy changes required but I believe the following are crucial to open the gates for real change for the rare disease community:

1. An EU policy goal should be: To ensure that European countries must have a clear implementation plan and budget for their National Rare Disease Plans (NRDP). No half measures should be acceptable. This can mean that we will have a real chance of not leaving anyone behind.


  • For anyone that was unaware, there was an EU directive in 2013 that all EU member countries had to develop and publish their own NRDP. Back then that was a huge win and I think most countries, or maybe all countries have now published a NRDP. Some of these plans are now expired and need to be renewed, updated, or prioritised. Some countries have made reasonable efforts and could present what they have implemented so far, but many have not acted properly in my opinion. If I am going to be totally honest, I believe most countries have failed to ensure there was a clear implementation plan and a red circled budget to ensure implementation. So where do we go now? Struggle on and hope it happens! No, I believe this would be a major failing.
 
  • I think Eurordis, relevant ERN’s, elected EU parliament representatives for each country and other key rare disease organisations that are lobbyists for rare diseases need to be aligned on this to ensure change. Collectively, I think we need to go back to the very people, at EU level, that helped to approve this EU policy change in 2013. We need to help them understand the failures and convince them that every European country must have an active NRDP, with a clear implementation plan and appropriate budget for implementation. It should not be token amounts for budgets. There should be enough funding to ensure that the objectives are realised. Most NRDP’s, to my knowledge, were four-year plans and their recommendations may need to be prioritised. I think patients are best placed to assist with prioritisation and there are many well informed rare disease patients and caregivers that can and will step up. We must do this!

2. An EU policy goal should be that every country, at the very least, must have a rare disease: Contact Registry (no sensitive data or clinical data). These should be run and kept updated by health ministries via their National Rare Disease Office. They should be heavily promoted by healthcare professionals in every hospital. When there is a rare disease diagnosis, enrolment should become a natural thing to promote.

  • Enrolment options into a national registry should be offered soon after diagnosis by the diagnosing health care professional (HCP). Such registries can open the doors to expand rare disease research. They can also increase the potential for patient benefit by understanding diseases better, in subsequent steps. Contact registries are a simplified way to really capture numbers of patients that are affected by specific rare diseases per country. They could offer information to patients such as the existence of disease specific registries that they might be able to join and include options for patients to be contacted if there are calls for patient involvement in research. The informed consents for enrolment would need to be cleverly written to maximise potential opportunities.
​
  • I love to hear of dedicated efforts for disease specific rare disease registries, for me they mean hope.  I often feel that we could all wait a lifetime hoping for each country to develop and manage rare disease registries for all rare diseases including adequate management of them. If we continue at the current pace with efforts to establish registries, I am fearful as to what success might look like in the medium to long term.​ When my son was diagnosed, I wanted to pursue science for MSD. When I contacted experts, they told me again and again that finding patients and securing funding for research were critical to help kick-start research. I believe that without a better understanding of many rare diseases, especially in the case of ultra-rare ones, that the dream of getting to clinical trials to try to prove potential treatments are effective, will not become a reality.  We should think of rare disease contact registries as stepping-stones to disease specific registries and a way to attract more research. I propose that every EU country (and beyond) should have a National Rare Disease Contact Registry (NRDCR).
If everyone believes we will achieve!
About Alan, MSD Action Foundation and SavingDylan.com

Alan is the research manager and founder of MSD Action Foundation and is working to accelerate research on MSD by supporting a pipeline of research that is showing great promise in supporting potential treatments and meaningful research advancements on MSD.

MSD Action Foundation and SavingDylan.com were established in 2015 by Dylan’s parents Alan and Michelle Finglas with the help of some wonderful volunteers and board members. The foundation aims to promote and support research advancements that will lead to improvements in clinical outcomes, life expectancy and quality of life for patients suffering from multiple sulfatase deficiency.
MSD ACtion Foundation / SavingDylan.com

0 Comments

Stabbed in the Back: Arachnoiditis: The childbirth I didn't expect

21/7/2020

0 Comments

 
Press Release 
Picture
​​Dinara Farina’s ‘Stabbed in the Back: Arachnoiditis: The childbirth I didn't expect’ takes readers on a walk alongside the author; through her hopes and dreams after emigrating from Russia to London, to the “routine” childbirth that changed her life forever. Dinara experience disabling pain  caused by arachnoiditis following an epidural,– a condition that is mostly misunderstood by the medical world.

​Her book is part autobiography and part clarion call to new mothers everywhere – raising vital awareness and sharing positive advice for a medical mystery, so often swept under the rug


"​After arriving in the UK from Russia in 2009, Dinara Farina looked forward to continuing her successful IT career and starting a family. She never expected to be a global advocate for arachnoiditis, a pain disorder caused by the inflammation of the arachnoid, a delicate membrane that protects the spinal cord.
 
Dinara first felt the pain of arachnoiditis following an epidural administered during the birth of her first child. Diagnosis was slow, and Dinara’s doctors missed their opportunity to treat the condition at the source.
 
In her new book, ‘Stabbed in the Back: Arachnoiditis: The childbirth I didn't expect’, Dinara puts a positive spin on the condition to share her life story with others, as well as offer actionable, practical advice to new mothers facing the same risks.
 
"I decided to turn my personal tragedy into something positive and channel my frustration into something meaningful. I decided to write this book to bring awareness about a hugely under recognised condition called arachnoiditis; a largely unknown side effect of childbirth epidurals that is more common than generally recognised. The idea came to me one year ago and it took me nearly a year to put ideas into words with the help of some great co-writers.  
 
"I honestly believe that my story can help many women out there make more informed decisions before they go in the labour ward. I am also highlighting the need to do a better job educating and preparing young moms on what to expect if they happen to require a medically assisted birth. The whole ecosystem needs to do a better job at educating and informing new mums
with postpartum pain to rule out arachnoiditis. 
 
"Dr Tennant, MD, PhD, a doctor who devoted over 40 years studying this disease, has given an endorsement to my book saying 'Dinara’s book will turn the tide.'

​"I do hope it will happen. I have a dream and pray that more research will be conducted and initiated in the UK for adhesive arachnoiditis!"


Stabbed in the Back: Arachnoiditis: The childbirth I didn't expect is available now: https://amzn.to/3dLWvrO

About the Author:
 
Dinara Farina, born in Samara, USSR in 1977, grew up in Russia and got her masters degree in English and foreign literature at Samara State University. She speaks four languages and has had a successful career in IT for over two decades, working and living in the UK since 2009.
 
A new author, Dinara is active in the global arachnoiditis community and hopes to bring awareness into the causes and drive more research into treatment of this debilitating condition. 
EMAIL DINARA

0 Comments

Team reflections on working through a global pandemic

20/7/2020

0 Comments

 
Picture
As the UK went into lockdown, and we closed the door on our small office, like many, we firmly anticipated this to be a three-week measure. Never could we have imagined that it would be five months before the world began its re-emergence.
Between our team we have nine school aged children, one family who were required to shield and, in May, one new recruit, so it's fair to say it has been a challenging juggling act for all. However, with adversity comes solidarity and with companies, regardless of geographic location, in the same boat relationships seem strengthened and opportunities for new ones opened up almost overnight, with the widespread adoption of the zoom call!

In this blog, five of our team members; Rebecca, Nicola, Daisy, Catherine and Emma, reflect on work and home life during a global pandemic.

​Many of you will know our colleague David who himself has a rare disease. David shared his own unique reflections which you can read in his blog My reflections on COVID-19

​
Picture
Rebecca Stewart, CEO, mum of three shares her reflections on keeping a business going and supporting a team during a global pandemic ​​

Businesses around the world have faced one of the most extraordinary challenges in modern history. Enforced closure, travel bans, and an uncertain economic future, threaten organisational chaos and are the cause of many sleepless nights for business owners.

As the pandemic rolled out across Europe and lockdown started to become a reality, we decided to move early and protect our team, packing up the small office and relocating our office team to their homes.
​Here at RARE Rev we have always offered flexible and remote working so the move was not too worrying or challenging and indeed for David and myself, who always work remotely, it was business as usual. Being a digital business meant we could also stay fully operational, so we feel immensely fortunate.
​
Operationally we owe all our success to the resilience of the team who have maintained productivity alongside juggling children, intermittent internet, and meeting interruptions. Their sheer tenacity and enthusiasm to carry on, delivering world class work with an upbeat and can-do attitude has been our saving grace, and I could not be more thankful or proud of their efforts. And whilst I do not think we are out of the woods by any means I am optimistic that our agility, flexibility and dedicated team will allow us to continue to innovate in rare disease communications well into the future.
​Nicola Miller, editor- in-chief and creative director is a mum of two primary aged children and a shielding family. Nicola has risen to the challenge of producing the latest summer edition, RARE Nephrology, whilst supporting her family through the isolation of keeping safe
​
Within days of closing our office in Ashford and starting remote working, my children were sent home from school for what was to be an indefinite period. Then a letter hit my door mat, followed by a series of texts and follow-up letters stating that our son was identified as medically extremely vulnerable to the effects of COVID-19, and was required by the government to medically shield for an initial period of 12 weeks. This was later extended to ​1 August, and the jury is still out on whether it will end then, as the country holds its breath to see if the adopted measures are working.
Picture
​Since March we have seen the entire season of spring come and go, and before we re-emerge summer will be all but over too. Working from home while home schooling brings its unique challenges, but as a shielding family, by far the biggest challenge has been complete and absolute social isolation.

With a clear directive from the government to avoid all “face-to-face contact”, our world has been confined to our home and garden, and the only faces we have seen are our friends and family over Zoom, and the odd fleeting glimpse of a neighbour heading to their car. As a family affected by rare disease, isolation is not a stranger to us, and comes with the territory, as does the practice of trying to dodge infection and virus’s, which is all  very normal for us, but this absolute isolation is a different level again!

There isn’t a day in the last 100+ that I haven’t counted my blessings that we have faced this head, on as a tight family of four with a strong love and bond, (which despite the inevitable home school headlocks, has grown immeasurably stronger over this period), and not, as many have, home alone.
​
We have been there for each other in the night hours when one or all of us can’t sleep, when we have each at times slipped into a lockdown funk and needed to be rallied back to good spirits, and when just the whole global situation has seemed so overwhelming. But for many this has been a crisis they have faced alone.  I for one, know that when my family are finally allowed out of this, and can once again embrace people, the biggest hugs and squeezes we have saved up during this time, will be going to those members of our family, friends and community who fall into that category and have faced this alone. 
​Daisy Marriott, communication assistant, joined our team during lockdown and has had to hit the ground running. Daisy reflects on first day nerves and and the unexpected technology benefits of remote working​
Picture


Starting a new job is daunting at the best of times, the night before nerves and unknown expectations is one thing. But another big thing for me is my lack of hearing and the fear of missing something vital in a conversation! That is all quite nerve wracking enough and then add into the mix a global pandemic with a lockdown, it becomes quite scary.

I was apprehensive about starting my new role from home, I felt like I would be missing the support network and comradery that comes naturally from being in an office environment. How wrong I was!
I have found working from home to be pretty much hiccup-free apart from the obvious video meeting call crashes and slow internet.
​I will miss the very short commute downstairs and as I am nearly always wearing ear bud headphones when speaking to the team, so the fear of mishearing anyone has diminished rapidly and I feel confident in conversation (I wish real life had a volume button). I also feel the reason I have adapted so well to working from home is mainly from the incredible support and guidance the RARE team have given me.

During my first week we had after-work virtual drinks which were brilliant, and I have never felt lost or alone despite being physically alone 9-5pm each day. I know there is always someone I can call on if I need advice and our group WhatsApp is never quiet. I have felt extremely grateful and even guilty sometimes that I have been given this opportunity at a time when many others have lost theirs.
​
I am really looking forward to being in the office and physically being part of the team and it will be a bonus having the added pressure to wear normal clothes again.  A little reminder for anyone that is working from home. Don’t forget to change out of your PJs BEFORE the meeting. 
​Catherine De Vaal, communications associate and mum to two primary aged children talks about guilt and her determination to onboard our newest team member will all the support she needed
​

​Like many working parents I constantly battle with time and guilt. The guilt of not being fully present when I am with my children because I am thinking of what I did not finish before I left the office. I know that Nicola, Emma and I used to dread those calls from school during office hours, wondering how sick they really are and then of course the guilt for even thinking that!

​​Well COVID-19 has amplified the pressure of not having enough time and oh the guilt has gone through the roof. I have spent the last few months apologising to pretty much everyone!
Picture
Which is why I have been incredibly lucky to have a supportive family, friends, colleagues and workplace, without whom I would certainly have lost my head and motivation.
​
​Daisy started working for RARE Revolution amid lockdown, I was absolutely determined to make her feel a part of the team and supported during a complex time to start a new job. We have been incredibly lucky that Daisy is so self-motivated and immediately slotted in, rising to every task she has been set.

Daisy works across the brands and team and so is given work tasks from multiple people. This can be challenging which is why we have regular contact with each other. When Daisy started, I gave her an onboarding document with logins and explanations to what she would be working on and the different platforms she would be using. We are in daily contact either with a scheduled catch up, via video calls and WhatsApp.
​
It doesn’t feel as though I have only met Daisy in person twice. She very much feels a part of the team and I cannot wait until we can sit across the room from each other without the dodgy internet connections and noisy children in the background!
Emma Bishop, design and editorial associate and mum to two primary aged children has shown her dedication and enormous talent editorially and more recently as a home schooler!
Picture

​
I look back on the day we closed-up the office, at the end of March, and said goodbye (not hugging!), and I cannot believe how little we knew back then! We honestly thought it would be a matter of weeks before we were back.

In an ideal world I would have set up my new home office in the spare room; a space dedicated to my work and somewhere I could physically, and psychologically, shut the door on at the end of each day. However, we are not living in an ideal world!
​I am not just working from home now, but also looking after and home schooling my two primary school children. And so, my new office is at the kitchen table. Working in design it is not just a case of having a laptop that I could set up anywhere—I need a laptop, plus a large monitor, which takes up a lot of space. My work area also doubles up as a school desk for my children.  On my new desk you will find a large monitor, a laptop, a keyboard, piles and piles of paper, maths sheets, glue, scissors, colouring pens, Mr Men books and the list goes on!

The benefits of having my workspace in the main family area is that I can work, but still be present, able to monitor my children. And it also means I can do some work when I get a free five minutes or the luxury of half an hour, often mid cooking dinner! This is also the downside though, as there is a tendency for work to encroach on homelife and for it to feel like I am never away from it. Having it all set up in the main family space means it is always at the forefront of my mind and it is very easy to keep dipping in and means I don’t have set working hours.

But it is what it is, it works, and I am incredibly lucky to be able to work from home and take care of my children too. For now, our new ‘normal’ works and allows us to all be together and safe, which is far more important than a perfect, tidy home office!

0 Comments

Why the Covid-19 pandemic may be particularly challenging for families living with rare conditions

17/7/2020

0 Comments

 
Picture
Families across the UK are experiencing major changes to daily life at the moment, but families of children living with rare genetic and neurodevelopmental conditions will experience some of the greatest impacts of the Covid-19 pandemic. While there has been a flurry of online surveys over the past few months, these are likely to overlook the specific challenges these families are facing. There is an urgent need for research to investigate the effects of the pandemic on mental health, particularly within these more vulnerable groups, in order to understand how to improve support.

Picture
Along with a UK-wide network of experts, I launched the CoIN Study to better understand the impact of the pandemic on mental health and wellbeing..
Charlotte Tye

​My existing research focuses on gaining a better understanding of the cognitive and behavioural difficulties that many people living with rare conditions face. Much of my research involves face-to-face assessment and so has been put on hold during the pandemic. When we started speaking to families involved in our studies to discuss remote assessment, the huge impact of the pandemic became clear. That’s why, along with a UK-wide network of experts, I launched the CoIN Study, which is an online study aiming to understand the impact of the pandemic on mental health and wellbeing in families of children with rare genetic and neurodevelopmental conditions.

Children with these rare conditions will often live with a unique combination of physical and mental health problems that have necessitated strict social distancing or shielding. Many will rely on a range of medical professionals, and access to this healthcare, and other intervention or treatment, has been drastically changed or removed during the pandemic. The mental health impacts of the pandemic will be felt for several months, even more so for these families, and the long-term effects of loss of support and healthcare are unknown.
We know that, even under normal circumstances, behavioural difficulties greatly impact upon quality of life in individuals with rare syndromes, and that families of children with rare syndromes experience anxiety, stress and low mood. The sudden change to daily life, such as carefully established routines and relationships, support networks, as well as professional support, combined with a higher risk of infection, is likely to impact upon wellbeing in both children and their parents, and even worsen existing difficulties. Because behavioural difficulties in children are associated with poorer mental health in parents, it is important that we understand their interaction during the gradual lifting of restrictions.

​A key part of the CoIN Study is to rapidly feed back results to the community, as well as to design and distribute tailored information and coping tips based on our participants’ responses. We’ll also be asking parents to help to design follow-up surveys and reports of our findings. Ultimately the results will be used to inform how we can best support families both now and in future disruptive emergencies.

Interesting in taking part? We’re asking parents of children aged from birth to 16 years old with a rare genetic or neurodevelopmental disorder to complete regular online surveys both during and after the pandemic.
Find out more and sign up on our website below:
​
Facebook
website
Twitter
0 Comments

Achalasia Action is shining a spotlight on a rare disease of the oesophagus: achalasia

15/7/2020

0 Comments

 
Picture
 Silvia Davey has a rare condition known as achlalasia and is a trustee at Achalasia Action, a charity recently formed to support people with the condition. Silvia talks to RARE Revolution about her personal experience of living with achalasia and why she and fellow members of a support group were driven to formalise and establish the charity
I will never forget the time my first esophageal spasm hit me. The excruciating chest pain and difficulties breathing convinced me I was having a heart attack. I was scared I might die. Only after getting home from accident and emergency, having been told I’d had a panic attack, did I start joining the dots together. Could this pain have been caused by my achalasia?

I’d had an operation for the condition five years earlier, yet not a single clinician had mentioned that I might develop heart attack like spasms down the line! 

About achalasia
 
Achalasia is a rare condition of the food pipe (the oesophagus) where the muscles and nerves that help propel food down towards the stomach stop working properly. It affects around 6,000 people in the UK, and causes a number of different symptoms, including the inability to swallow food (dysphagia), chest pain, spasms, aspiration and regurgitation of food. Ultimately, achalasia can cause severe weight loss and malnutrition, lung infections, and impact on a person’s wellbeing and mental health. 

Given its rarity, and its disparate symptoms, it often gets misdiagnosed. People with achalasia can experience these symptoms for many years, and even decades, before they get a correct diagnosis. Although there are no effective treatments for the condition, symptoms can be managed with lifestyle changes, or relieved by operations that open-up the entrance to the stomach (Heller myotomy or peroral endoscopic myotomy), Botox injections or balloon dilations. These solutions are not always effective, and the symptom relief may be short-lived. 
 
My story of achalasia

I developed achalasia when I was 17. After an initial misdiagnosis, where I was told I had an eating disorder, I was fortunate enough to be diagnosed in a matter of months and be operated on by one of the leading achalasia clinicians in Italy. I lived my late teens and early twenties pain free, bar the occasional bout of acid reflux. When I developed the spasms and started finding it difficult to eat again, I decided to seek further medical advice. But I was lost. Hundreds of miles away from home, in the British healthcare system, I didn’t know how to get the support I needed. 
A trip to the GP was pointless: they had never treated a person with achalasia before, and I was referred to a hospital that did not have any specialists that knew about the condition. To be clear, I do not blame the GP for any of this. Awareness of achalasia is extremely poor amongst the healthcare community—it is barely researched or studied, and very few healthcare workers and clinicians have good knowledge of the condition. We know so little about it that even the exact cause of why the nerves that control the muscles of the oesophagus stop working remains unknown. ​
Silvia Daley
I was back to square one. Cue more Googling, and I came across the Achalasia Meetup group. Set up by Amanda Ladell (now an Achalasia Action Trustee), the group brings together people with achalasia once a month, to share experiences and exchange hints about the condition. In 2013, this group also started meeting twice a year with members of the Oesophageal Patients Association (OPA), to learn more about the disease under the guidance of consultant surgeon Majid Hashemi from University College Hospital, and other researchers and academics specialising in the condition. These meetings, and the kindness of all the members that attend them, were immensely helpful at the time and have continued to be throughout the years. They have helped me identify a specialised surgeon, have armed me with numerous diet hints, and have empowered me to make changes to my lifestyle that have dramatically improved my symptoms.  
​Achalasia Action was born
​

In 2019, several the group’s members decided to come together and formalise the group’s activity as a registered charity, Achalasia Action. The charity’s purposes include:
  • To provide education and raise public awareness about achalasia and associated conditions
  • To alleviate physical or mental distress of persons with achalasia including their friends and families
  • To encourage and support research into achalasia for the public benefit.
Under the guidance of its chair Alan Moss and seven trustees, the charity is now officially registered with the Charity Commission and has a website where people with achalasia can access support information and the latest achalasia-related news. It continues running its monthly and bi-yearly patient meetings, provides informal peer support to those in need, and has helped support regional achalasia meet-up groups across the country. It has also grown its social media presence and has started accepting generous donations from its supporters.

Further information

If you’d like to find out more about achalasia and the charity’s work, using the buttons below you can visit Achalasia Action’s website. We also have a Facebook page, Facebook group, and you can follow us on Twitter. If you’d like to support our charity, you can donate here. If you have any questions, or would like to volunteer, we would love to hear from you on 
info@achalasia-action.org
Twitter
Achalasia Action
Facebook

0 Comments

My reflections on COVID-19

10/7/2020

1 Comment

 
RARE Revolution’s David Rose, is our business development associate and an ultra-rare disease speaker. David reflects on life during lockdown, navigating work, managing his health and throwing his relationship in at the deep end. 
Picture

​The world has been a very different place over the last few months – I’m sure we can all agree on that. The COVID-19 pandemic has dominated the news since January and every aspect of our lives.

I moved in with my girlfriend a week before lockdown started here in the UK – we were very lucky in the timing. Due to the restrictions that were put in place – many of those in relationships who were not already living together found themselves having to be apart.

The frenetic pace of life has slowed for many of us

COVID-19 has made many of us rethink life in general and how we go about it. Before the pandemic much of the UK were living a very fast-paced lifestyle. Many of us had long working commutes and busy schedules, suddenly the majority of the population were forced to stay at home, no longer commuting and were very restricted in our activities. Perhaps, many in the UK, either by choice or no choice will have to rethink this lifestyle and go about life at a slower pace than before?
I work from home, so the big shift for people working in office spaces, now having to work from home, has not affected me. However, the same cannot be said about my health.
Managing my health during COVID-19
I think being ill my whole life has given me an odd advantage over healthy people during this outbreak.

Healthcare has and will continue to be affected in many ways throughout this pandemic.

For me personally, I’ve been more concerned about my own rare disease and the other conditions I have rather than COVID-19 itself. I’ve had plenty of near-death experiences growing up. I think that has made me look at my life a bit differently and made me very relaxed about things – not sure if that’s good or bad!

I think being ill my whole life has given me an odd advantage over healthy people during this outbreak. I have had dozens of operations and procedures and so have become used to long periods of recuperation and having to rest, spending a lot of time at home and being very idle.

However, my health issues have continued throughout this period and it has been an especially tough time to be ill, as many of the services I would normally access and take for granted have been unavailable or heavily restricted. My local GP shut a few weeks back, thankfully, they were available to help via the telephone to ensure I could still get my medications etc.
 
Since February and especially during March my health has been very up and down. Before the pandemic, this would have involved at least two trips to A&E when I was feeling particularly ill, but because of COVID-19 and the pressure on the NHS I felt I really had to stay out of hospital.

Many of those in the UK living with a rare/chronic condition received a letter from the government or their hospital. I received my letter saying that I’m in the ‘high risk’ category, but not required to shield. In all honesty, I wasn’t sure whether I should still shield or not – but I chose not to.
Picture
David at a recent hospital visit and in networking mode!
Moving to the next phase of COVID-19

At the time of writing this, I’m a few days away from attending my first hospital appointment in person for several months. As I said, my rare disease has been causing a lot of issues, especially during the past few weeks – so I’m looking forward to attending hospital – quite a weird expression, I know! It’ll be a weird sensation to leave my local area for the first time in months and to use public transport again.

Now that hospitals are starting to open a bit more, I imagine that the waiting lists for non-urgent appointments and operations will be through the roof. I think it will take quite some time for hospitals to recover from this backlog.

Telemedicine could well be the new normal in healthcare. Most of my clinic appointments have either been postponed or turned into calls, or even video calls. I think this will be the new normal for healthcare. Although you may not get the same benefits of seeing your healthcare professional in person, telemedicine has many advantages. Most notably, the cost of time and money.

The NHS staff have done an incredible job during this pandemic. I am so thankful to them all the time, as they always do a great job in looking after me on a day-to-day basis. But, having seen their dedication and the powerful images and videos online throughout the pandemic – it has really hit home how incredible they are.

Personally, COVID-19 has made me connect with my friends and family in a different way. Although we can now meet up albeit in a socially distanced way, for the first few weeks we turned to chatting via facetime and I have taken part in more quizzes than I could ever have imagined! And we still continue to stay in touch like this.

I can’t believe how fast the time has gone over the last few weeks – I really thought time would drag on.​
It’ll be interesting to see how the next four months go – how do you think things will change in this next chapter? 
1 Comment

“I Stay Home For Rare” Financial Assistance Campaign Launched by Living in the Light.

8/7/2020

0 Comments

 
Picture
''I Stay Home For Rare'' was launched in April 2020 to help people living with rare diseases and economic challenges during COVID-19. In response to the COVID-19 pandemic, Living in the Light, a patient advocacy company that specialises in rare disease storytelling through photography, narrative journalism and documentary video, launched I Stay Home For Rare , a campaign and fund to provide immediate financial relief and assistance to members of the rare disease community.
We are a small but mighty team leading this effort
Levi Gershkowitz, founder and CEO of Living in the Light
​In the first week of the campaign, I Stay Home For Rare formed partnerships with 12 different patient advocacy organisations nationally and raised over $45k, enough to significantly help 30 families pay their rent, buy food, and for some, provide vital therapies for their children who have lost access due to the pandemic. 
We are raising and distributing emergency funds as quickly as possible as we adjust to this new global landscape
Levi Gershkowitz founder and CEO of Living in the Light
​One unique aspect of the campaign is Living in the Light’s commitment to empowering families and individuals to share their stories and to openly address the isolation often associated with having a life-limiting condition—something many people are now dealing with for the first time due to social distancing protocols. The company is conducting ongoing interviews with members of the rare disease community internationally and sharing excerpts of their stories through social media and online platforms. 

Stories highlight these challenges such as: a blind social worker living with Leber hereditary optic neuropathy who describes the difficulty of obtaining groceries amidst the backlogged food delivery services he relies on; a graduate student and poet with sickle cell disease who has been told to forego the outpatient pain management he needs in order to function; and an immunocompromised senior management partner at Google living with Duchenne muscular dystrophy who continues to work, but now lives in social isolation with his caregiver who is needed to help with routines to maintain lung function.
Sharing stories of resilience has been at the foundation of Living in the Light’s mission since 2012. ​
​In solidarity with the rare disease community, the company has brought their expertise in narrative medicine and community organising to expand the patient advocacy efforts of numerous biotech and pharmaceutical companies, universities, and national patient organisations.Through the campaign website www.IStayHomeForRare.org one can make a tax-deductible  donation or apply for funds, which are being distributed in grants of up to $2,500 per family/household. In addition to leading this effort, Living in the Light made an initial contribution of $10,800 to begin the first funding series. ​
There are valuable and vulnerable lives that depend on our collective effort right now. Regardless of the size of this campaign, we wanted to do something to advocate for our rare disease community during this unprecedented time, we welcome the support of industry to join us in fulfilling their corporate
responsibility to serve the rare community during this time, we are all in this together

Levi Gershkowitz
Picture

For more information about 'I Stay Home for Rare' go to the website ​or contact Levi Gershkowitz using the buttons below.
​
To stay up to date with the campaign follow #istayhomeforrare or find Living in the Light on Instagram at @frompatienttoperson. 
Picture
Email
Living In the Light Website
Levis Gershkowitz Email
IStayHome4Rare Website

0 Comments

Kawasaki Disease UK

1/7/2020

0 Comments

 
Picture
​​Kawasaki disease (mucocutaneous lymph node syndrome) mostly strikes babies and children under the age of five. It initially presents as a high fever that lasts for five days or more AND involves at least three of the following five symptoms: swollen glands, an angry rash, red swollen hands and feet, dry cracked lips/strawberry tongue, and bloodshot/infected eyes. In many cases, this disease causes serious and irreparable damage to the heart (usually in the form of aneurysms caused by inflammation in coronary arteries). Since Kawasaki disease symptoms are commonly seen in other general infections – including influenza and bacterial meningitis – misdiagnosis is tragically commonplace among parents and GPs.
​
Kawasaki disease is now recognised as the leading cause of coronary heart disease in children with effects that may be permanent for those who survive into adult life. It is the prime suspect in death by non-congenital heart failure among children and young adults. There has been a relentless increase of Kawasaki disease-related hospital admissions (from 507 in 2015/16 to 628 in 2017/18 - of which two-thirds were emergencies) in England and Wales, not to mention the undiagnosed, misdiagnosed, and adult statistics. In addition, there is some evidence of an up to a 10 per cent chance that susceptibility to Kawasaki disease is hereditary. 

Although there is no evidence that sufferers are contagious during its active phase, it is possible that Kawasaki disease is airborne. If its victims survive their childhood, those worst affected and undiagnosed continue to have myocardial and vascular complications as adults. The number of Kawasaki disease victims later diagnosed has increased by 1,400 since 2009: and reported cases of Kawasaki disease probably represent just the tip of the iceberg.


How is Kawasaki disease treated?
​ 
​
If diagnosed within the first 10 days of acute Kawasaki disease, high doses of intravenous immunoglobulin (IVIG) and aspirin have proven to be most effective in combating inflammation and in reducing the chance of sustaining damage to the coronary arteries. 
These treatments continue until the initial phase subsides.


​
What can I expect once my child comes home from the hospital?
​


Once discharged from hospital, your child may continue to be tired and have a poor appetite. However, unless otherwise specifically advised by your doctor, you should not attempt to limit your child’s activity or diet.

​

Although reoccurrence of KD is extremely rare, should symptoms and signs recur, call your doctor immediately.
What are the consequences if the disease is not properly treated? 
​
Initially, its symptoms including fever, swollen lymph nodes (or swollen glands) in the neck, rashes, and mucous membrane inflammation can all be extremely uncomfortable and may last for 1 to 3 weeks. With treatment, the fever and other symptoms usually subside within 24 hours. 

Untreated, in the later stages of Kawasaki disease, about 25% of affected children develop heart problems of varying severity.
 You should call your doctor if any of the following occurs:
  1. The fever returns within the first week after leaving hospital.
  2. Tenderness of the large joints (hips, knees) making your child unwilling to walk or move about as before.​
*Routine live virus immunisation for measles, mumps, and rubella (MMR) and chickenpox (varicella) should be delayed for 12 months following IVIG treatment because the IVIG contains antibodies that will neutralise the vaccines. If your child has a history of eczema, KD may cause a flare-up of this rash, which is very itchy. The usual treatment for eczema should be started and you should consult your paediatrician.

Signs and symptoms include: 

  • A fever that lasts for 4 days or more
  • Swollen glands
  • Angry rash 
  • Cracked dry lips/strawberry tongue/mouth ulcers 
  • Red bloodshot infected eyes 
  • Red swollen peeling hands and feet. 
If your child has four or more of the above symptoms for more than four days, ask the doctor for a heart scan by a paediatric cardiologist. 
Picture

More information about Kawasaki Disease UK 
Kawasaki Disease UK aims to help parents self-diagnose and identify the classic symptoms by day five, before the
critical phase of heart damage 11-13 days of the onset and aid recovery with treatment that prevents cardiac arrest in a young life. 
​
To get in touch,for more information, parent guide and latest research please use the buttons below. 


Parent Guide
Website
Email
Latest Research
​ Dee Izmail - Founder of Kawasaki Fund   
KAWASAKI FUND  REG. CHARITY NO.: 1064518 
 
      KAWASAKI DISEASE UK LTD
. REG. NO.: 11375141       

0 Comments

    Author

    Rare Revolution Editor

    Archives

    December 2020
    November 2020
    October 2020
    September 2020
    August 2020
    July 2020
    June 2020
    May 2020
    April 2020
    March 2020
    January 2020
    December 2019
    November 2019
    October 2019
    September 2019
    August 2019
    July 2019
    June 2019
    May 2019
    April 2019
    March 2019
    February 2019
    January 2019
    December 2018
    November 2018
    October 2018
    September 2018
    August 2018
    June 2018
    May 2018
    April 2018
    February 2018
    January 2018
    November 2017
    October 2017
    August 2017
    July 2017
    June 2017
    May 2017
    April 2017
    March 2017
    February 2017
    January 2017
    December 2016
    October 2016
    September 2016
    July 2016

    Categories

    All

Rare Revolution is published by NRG Collective, a not-for-profit media company specialising in rare disease content
Contact Us
Editor:  
   editor@rarerevolutionmagazine.com
​Advertising: rstewart@rarerevolutionmagazine.com

  • Home
  • Rare Revolutionaries
    • Our Charity Partners
    • Revolutionaries Community
    • Join the Rare Revolution - Charities sign-up
    • Our Corporate Friends
  • Blog
  • Back Issues
  • #RareYouthProject
    • RYP Blog
  • The People of RARE
    • CEO Series
  • APP & Downloads
  • Media